Decatur Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-101,525
Closed -$6.51M 64
2018
Q4
$6.51M Buy
+101,525
New +$7.49M 1.46% 31
2017
Q4
Sell
-81,623
Closed -$11.9M 55
2017
Q3
$11.9M Buy
81,623
+4,675
+6% +$637K 2.28% 10
2017
Q2
$9.99M Sell
76,948
-7,897
-9% -$968K 2.1% 18
2017
Q1
$10.6M Sell
84,845
-26,030
-23% -$3.12M 2.05% 14
2016
Q4
$12.8M Buy
+110,875
New +$12.3M 1.84% 17
2016
Q1
Sell
-108,000
Closed -$12.9M 113
2015
Q4
$12.9M Sell
108,000
-600
-0.6% -$69.4K 1.66% 33
2015
Q3
$11.7M Buy
+108,600
New +$13.5M 1.6% 35

Other funds holding CELG

Decatur Capital Management's CELG Position: Q1 2019 in Review

Decatur Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 101,525 shares — an estimated $6.51M sold.

Decatur Capital Management first reported a position in CELG in Q3 2015 and held it in 7 quarters. The position peaked at $12.9M in Q4 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Decatur Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Decatur Capital Management sold 101,525 Celgene Corp shares in Q1 2019, an estimated $6.51M.
  • Decatur Capital Management first reported a position in Celgene Corp in Q3 2015 and held it in 7 quarters.
  • Decatur Capital Management's Celgene Corp position peaked at $12.9M in Q4 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Decatur Capital Management's 13F filing for Q1 2019, filed 23 Apr 2019.